Historical Valuation
Inspire Veterinary Partners Inc (IVP) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Inspire Veterinary Partners Inc (IVP) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.04
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Inspire Veterinary Partners Inc (IVP) has a current Price-to-Book (P/B) ratio of 0.07. Compared to its 3-year average P/B ratio of 2.45 , the current P/B ratio is approximately -97.12% higher. Relative to its 5-year average P/B ratio of 2.45, the current P/B ratio is about -97.12% higher. Inspire Veterinary Partners Inc (IVP) has a Forward Free Cash Flow (FCF) yield of approximately -191.56%. Compared to its 3-year average FCF yield of -216.70%, the current FCF yield is approximately -11.60% lower. Relative to its 5-year average FCF yield of -216.70% , the current FCF yield is about -11.60% lower.
P/B
Median3y
2.45
Median5y
2.45
FCF Yield
Median3y
-216.70
Median5y
-216.70
Competitors Valuation Multiple
AI Analysis for IVP
The average P/S ratio for IVP competitors is 0.05, providing a benchmark for relative valuation. Inspire Veterinary Partners Inc Corp (IVP.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of 6.60%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for IVP
1Y
3Y
5Y
Market capitalization of IVP increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IVP in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is IVP currently overvalued or undervalued?
Inspire Veterinary Partners Inc (IVP) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Inspire Veterinary Partners Inc (IVP) is between to according to relative valuation methord.
What is Inspire Veterinary Partners Inc (IVP) fair value?
IVP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Inspire Veterinary Partners Inc (IVP) is between to according to relative valuation methord.
How does IVP's valuation metrics compare to the industry average?
The average P/S ratio for IVP's competitors is 0.05, providing a benchmark for relative valuation. Inspire Veterinary Partners Inc Corp (IVP) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 6.60%, this premium appears unsustainable.
What is the current P/B ratio for Inspire Veterinary Partners Inc (IVP) as of Jan 09 2026?
As of Jan 09 2026, Inspire Veterinary Partners Inc (IVP) has a P/B ratio of 0.07. This indicates that the market values IVP at 0.07 times its book value.
What is the current FCF Yield for Inspire Veterinary Partners Inc (IVP) as of Jan 09 2026?
As of Jan 09 2026, Inspire Veterinary Partners Inc (IVP) has a FCF Yield of -191.56%. This means that for every dollar of Inspire Veterinary Partners Inc’s market capitalization, the company generates -191.56 cents in free cash flow.
What is the current Forward P/E ratio for Inspire Veterinary Partners Inc (IVP) as of Jan 09 2026?
As of Jan 09 2026, Inspire Veterinary Partners Inc (IVP) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Inspire Veterinary Partners Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Inspire Veterinary Partners Inc (IVP) as of Jan 09 2026?
As of Jan 09 2026, Inspire Veterinary Partners Inc (IVP) has a Forward P/S ratio of 0.00. This means the market is valuing IVP at $0.00 for every dollar of expected revenue over the next 12 months.